Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Superficial Venous Thrombosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Not applicableWithdrawnNCT04136561
What this trial is testing

Novel Strategy to Encourage Early Removal of Central Venous Catheters

Who this might be right for
Vascular Access ComplicationCentral Line ComplicationCentral Line-Associated Infection+2 more
Corewell Health East
Not applicableStudy completedNCT02875899
What this trial is testing

Surfacer System to Facilitate Access in Venous Occlusions

Who this might be right for
Chronic Venous ThrombosisVenous Thrombosis Upper ExtremityVenous Thrombosis Upper Extremity Superficial Veins
Merit Medical Systems, Inc. 30
Large-scale testing (Phase 3)Study completedNCT00443053
What this trial is testing

Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)

Who this might be right for
Thrombosis, Venous
GlaxoSmithKline 3,002
Post-approval studies (Phase 4)Study completedNCT05001776
What this trial is testing

Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein

Who this might be right for
Superficial Vein ThrombosisEndovenous Laser Ablation
National Medical Research Center for Therapy and Preventive Medicine 105
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07663825
What this trial is testing

Acetylsalicylic Acid Versus Placebo as an add-on Treatment to Local Non-steroidal Anti-inflammatory Drug for the Management of Thrombotic Episodes in Superficial Venous Malformations in Children Aged 6 to 17 Years.

Who this might be right for
Venous Malformation, Low FlowVenous Malformations
University Hospital, Tours 34
Large-scale testing (Phase 3)Study completedNCT01499953
What this trial is testing

Superficial Vein Thrombosis (SVT) Treated With Rivaroxaban Versus Fondaparinux

Who this might be right for
Superficial Vein Thrombosis
GWT-TUD GmbH 472
Not applicableStudy completedNCT07290608
What this trial is testing

DOACT Algorithm Versus AI-Based Decision Models in Oral Anticoagulant Therapy for Vascular Patients

Who this might be right for
Deep Vein ThrombosisSuperficial ThrombophlebitisPulmonary Thromboembolisms+2 more
ITALO EUGENIO SOUZA GADELHA DE ABREU 59
Not applicableLooking for participantsNCT07388381
What this trial is testing

Superficial Vein Thrombosis of the Upper Limb in Bacteremia Associated With PICCline and Midline Catheters: Frequency and Clinical Consequences

Who this might be right for
Catheter Associated Infection
Centre Hospitalier Universitaire de Nice 150
Testing effectiveness (Phase 2)Study completedNCT03428711
What this trial is testing

Mesoglycan (Prisma®) Versus Placebo in Secondary Prevention of the Superficial Venous Thrombosis

Who this might be right for
Superficial Venous Thrombosis of Leg, Secondary Prevention
Quovadis Associazione 560